Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
Australia
Prince of Wales Hospital, Sydney, New South Wales Royal Prince Alfred Hospital, Sydney, New South Wales Concord Repatriation and General Hospital, Sydney, New South Wales Nepean Hospital, Sydney, New South Wales Westmead Hospital, Westmead, New South Wales